Merdan S, Barnett CL, Denton BT, Montie JE, Miller DC. OR practice–data analytics for optimal detection of metastatic prostate cancer. Oper Res. 2021 May;69(3):2-4. doi: 10.1287/opre.2020.2020
Connor MJ, Khoo V, Watson V, Ahmed HU. Radical treatment without cure: decision-making in oligometastatic prostate cancer. Eur Urol. 2021 Apr;79(4):558-60. doi: 10.1016/j.eururo.2021.01.029
Skinner CS, Schildkraut JM, Calingaert B, Hoyo C, Crankshaw SS, Fish L, Susswein L, Jasper C, Reid L. Factors associated with African Americans' enrollment in a national cancer genetics registry. Community Genet. 2008 Apr 1;11(4):224-33.
DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Keininger D, Marquis P. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol. 2005 Sep 1;48(3):503-11.
Overland GB, Vatten L, Rhodes T, DeMuro C, Jacobsen G, Vada K, Angelsen A, Girman CJ. Lower urinary tract symptoms, prostate volume and uroflow in Norwegian community men. Eur Urol. 2001 Jan 1;39(1):36-41.